VANCOUVER, BC, September 23, 2021 – ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children nutrition company, is pleased to announce high market penetration and sales growth rates across online and retail channels:
US Product Launch:
Else Plant-Based Complete Nutrition for Toddlers, available in Sprouts Farmers Markets (350 doors) since February 2021, has extended to many additional natural food and grocery retailers and independent stores, including Big-Y, Raley’s, Natural Grocers AFS, Haggen, PCC, Mother’s Markets, Huckleberry’s Natural Market, Rouses Markets, Harmons, Roche Bros., and more than 100 independent and co-op stores.
Else is listed in 1,100+ stores and is sold on the shelves of 800+ of these and continues to grow. In less than six (6) months, Else’s sales velocity in Sprouts crossed the 1 (one) UPSPW KPI (Units per Store per Week) target level ahead of expectations for the category targeted for the first 12 months.
Else onboarded and is shipping product to the 2 largest natural food distributors in North America – UNFI and KeHE Distributors, which together cover almost the entire retail market in the US. Combined they have opened 14 distribution centers to supply retail stores.
Else and its retail brokers, with the active assistance of its distributors, are in discussions with dozens of additional large, small and independents natural food, grocery and drug retail chains, that together represent more than 5,000 stores.
Else started its U.S. online sales in August 2020 on www.elsenutrition.com and in late September on Amazon.com. Initial online sales on these two channels have demonstrated a good growth trajectory, growing at more than 10% month-over-month, and are expected to accelerate as more products are added to the Else range. Else’s Amazon.com monthly sales have grown close to 600% since launch.
Else products are also sold on the iHerb international online retail platform (US, Canada, 180 international markets) and on Thrive Market, a leading U.S. online platform that has 500,000+ subscribers. Else plans to list on additional leading online platforms in the coming months. The Company signed listing agreements and is completing the on-boarding process with Walmart.com and with Kroger-owned online platforms, both expected to significantly boost Else online reach. Launch is expected in Q4 2021.
In June 2021, Else launched a new product line – Plant-Powered Complete Nutrition for Kids, 2 years and older. The product is offered initially in vanilla and chocolate flavors, in 16 oz powder cans. This new product line offers a superior, plant-based, low sugar, delicious alternative to milk and soy-based products that are currently in the market. This launch has been extremely successful thus far, with the new line already accounting for 25%+ of total unit sales on www.elsenutrition.com.
In Q4 2021, Else Nutrition plans to launch a series of Plant-Based complementary nutrition products for babies 6 months and older, in several flavors.
Early next year Else plans to launch liquid RTD (Ready-To-Drink) versions of its Complete Nutrition for Kids products, and a non-organic (and more affordable) version of its successful Toddler product.
These new SKUs will grow Else’s product range and are expected to further accelerate sales in all channels. These products (in different SKUs and minor variations) will be offered in the U.S., Canada, Europe, and other markets.
International Product Launch Plans
Else plans to offer Canadian tailored products for sale in Canada, online, and in retail channels. Launch is planned for Q1 2022.
After developing a series of products that comply with the European Directive, Else is progressing towards a distribution agreement in France with H&H Group.
Additionally, Else is in discussions with the H&H group with regards to the distribution of its product line via the H&H cross-border China platform.
Else plans to start selling its products in Europe early next year.
The Company continued to drive customer awareness, conversion, and sales at scale through:
The company completed its 8th commercial manufacturing run since July last year, and successfully built inventory to service the online and retail expansion in the U.S. market and beyond.
“In the last few months, we improved our manufacturing processes and product quality, to consistently produce a high quality easily dissolved tasty product,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. “Our new kid’s products can be prepared in a cup or a shaker with cold water, something both kids and parents love and appreciate.” She added.
U.S. Operations and Medical Marketing/Scientific Affairs:
The Company hired a former Divisional VP at Abbott Nutrition EMEA, Mr. Simeon Saunders, who will spearhead growth in the Key Global Medical Marketing Channels as well as lead the scientific & clinical global affairs of the Company.
The Company also hired a former Senior Director of Pediatric and Adult Nutrition at Abbott Nutrition US, Mr. Mike Glick, as North America General Manager, to lead its HCP (Health Care Practitioner) marketing strategy and operations. Under Mike’s leadership, the Company launched a new website targeting the HCP community and has launched a long term HCP marketing & educational program targeting over 80,000 North American pediatricians.
The company is conducting several clinical studies to obtain marketing permits for infant formula in USA and EU and to demonstrate scientifically that Else line of products supports growth and that the products are well tolerated by young children, either healthy or with different sensitivities. The company is in final preparations for a growth study in healthy toddlers and finalizing protocols for a hypo-allergenicity study in toddlers with cow milk allergy.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc., is a publicly-traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives include leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics, and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit elsenutrition.com or @elsenutrition on Facebook and Instagram.
For more information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
Mr. Sokhie Puar, Director of Else Nutrition
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.